Clinical trial
An Observational Cohort Study on the Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
NCT04303962 is registered in ClinicalTrials.gov with Ning Wang, MD., PhD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Cohort Study on the Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
- Lead sponsor
- Ning Wang, MD., PhD.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 27, 2020
- Completion date
- January 21, 2025
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.